Overview

Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The objective is to provide data supporting the use of LAS40464 as an efficacious and safe maintenance bronchodilator treatment of patients with Chronic Obstructive Pulmonary Disease (COPD).
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Bromides
Formoterol Fumarate